Interaction between serotoninergic-and beta-adrenergic receptors signaling pathways in rat femoral artery by Delbin, M.A. et al.
Original Article
Interaction between Serotoninergic-and β-adrenergic Receptors 
Signaling Pathways in Rat Femoral Artery
Maria Andréia Delbin1, Alexandre Sérgio Silva1, Edson Antunes2, Angelina Zanesco1  
Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)1, São Paulo, SP; Universidade Estadual de Campinas (UNICAMP)2, Campinas, 
SP, Brazil
Abstract
Background: Coronary heart disease has been widely studied in cardiovascular research. However, patients with 
peripheral artery disease (PAD) have worst outcomes compared to those with coronary artery disease. Therefore, 
pharmacological studies using femoral artery are highly relevant for a better understanding of the pathophysiologic 
responses of the PAD.
Objective: The aim of this study was to evaluate the pharmacologic properties of the contractile and relaxing agents in 
rat femoral artery. 
Methods: Concentration response curves to the contractile phenylephrine (PE) and serotonin (5-HT) and the relaxing 
agents isoproterenol (ISO) and forskolin were obtained in isolated rat femoral artery. For relaxing responses, tissues 
were precontracted with PE or 5-HT.
Results: The order rank potency in femoral artery was 5-HT > PE for contractile responses. In tissues precontracted 
with 5-HT, relaxing responses to isoproterenol was virtually abolished as compared to PE-contracted tissues. Forskolin, 
a stimulant of adenylyl cyclase, partially restored the relaxing response to ISO in 5-HT-precontracted tissues.
Conclusion: An interaction between β-adrenergic- and serotoninergic- receptors signaling pathway occurs in femoral 
artery. Moreover, this study provides a new model to study serotoninergic signaling pathway under normal and 
pathological conditions which can help understanding clinical outcomes in the PAD. (Arq Bras Cardiol 2012;98(1):29-34)
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surgical interventions and discovery of new pharmacological 
therapies, patients with PAD have worst outcomes 
compared to those with coronary artery disease5. For that 
reason, pharmacological studies using femoral artery are 
highly relevant for a better understanding of clinical and 
pathophysiologic responses of the PAD.
It is well known that serotonin (5-hydroxytryptamine, 
5-HT) plays  important  biologic funct ions in the 
cardiovascular system including platelet aggregation, 
bradycardia or tachycardia, hypotension or hypertension, 
and vasodilatation or vasoconstriction6,7. The diversity of the 
functional actions of the 5-HT relates to its receptor subtypes 
number as well as to the complexity of the signaling pathway 
involved in their responses. In this regard, at least fifteen 
5-HT receptor subtypes have been characterized which are 
subdivided into seven receptor families according to their 
pharmacologic properties, amino acid sequences, gene 
organization, and second messenger coupling pathways8,9. 
The 5-HT1, 5-HT2, 5-HT4, 5-HT5, 5-HT6, and 5-HT7 
receptor families are coupled to G-proteins, whereas the 
5-HT3 receptors are 5-HT-gated ion channels. Among the 
5-HT receptors, 5-HT1 and 5-HT2 receptors subtypes play 
an important role in the cardiovascular system regulation 
Introduction
Femoral artery is an important branch of the iliac 
artery that irrigates the lower limb skeletal muscles and 
peripheral tissues and it is a unique blood vessel with a long 
conduction, high-flow resistance and a striking relevance for 
medical interventions1. Indeed, approximately 50% of all 
athero-occlusive disease takes place in the femoral artery 
which can result in intermittent claudication and critical 
limb ischemia with significant impairment of patients’ 
daily activity2. The incidence of peripheral artery occlusive 
disease (PAD) has been increasing in the world population 
and considerable efforts have been made to improve the 
poor interventional outcomes in long-term treatment. 
Moreover, factors such as smoking, dyslipidemia, diabetes 
mellitus, atherosclerosis and advancing age have been 
implicated in the pathogenesis of the PAD3,4. Although 
most of the many cardiovascular researches have been 
focused on the coronary heart disease such as advances in 
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where 5-HT1 receptor family is mostly linked to Gi/o protein, 
which inhibit cAMP formation, whereas 5-HT2 receptors 
family is coupled preferentially via Gq/11 protein leading 
to the activation of IP3/PKC/cytosolic [Ca2+] signaling 
pathway10. Both 5-HT1 and 5-HT2 receptor families have 
been associated with contraction of vascular smooth muscle 
and thrombus formation9,11.
The activation of α- and β-adrenergic receptors by 
catecholamines also produces a number of functional 
responses in the cardiovascular system including positive 
chronotropic responses and vascular tone control12,13. 
The α–adrenergic receptor-mediated vasoconstriction 
has been widely studied under normal and pathological 
conditions14-16, but few studies evaluate the β-adrenergic 
receptors-mediated vasodilatation17,18. In this regard, at 
least three β-adrenergic receptors subtypes mediate the 
relaxation responses in vascular tissues, which are coupled 
to Gs protein leading to the activation of cAMP-dependent 
protein kinase (PKA) signaling pathway19.
Either serotoninergic or adrenergic receptors signaling 
pathways are targets for the treatment of the cardiovascular 
diseases including heart failure, arterial hypertension, 
coronary artery disease and PAD4,20. Thus, pharmacological 
studies regarding small arteries and the interactions 
between drugs involving both serotoninergic and adrenergic 
receptor signaling pathways are crucial for developing new 
compounds in a attempt to improve the quality of life of 
patients with vascular disease. Therefore, the objective of 
this study was to evaluate the pharmacologic properties 
of the contractile (5-HT and phenylephrine) and relaxing 
agents (isoproterenol and forskolin) in the proximal segment 
of rat femoral artery. 
Methods
Animals
This study was approved (protocol: 1307-1) by the 
Ethical Committee of the Medical School of Universidade 
de Campinas (UNICAMP). They were individually housed 
at 26 ± 2 oC with food and water delivered ad libitum on 
a 12 h light: dark cycle with the lights turned on at 6:00 
a.m. Male Wistar rats (407±6g) were stunned by inhalation 
of CO2, euthanized by decapitation, and exsanguinated. 
Rat isolated femoral artery rings 
The femoral artery was quickly removed and placed 
in chilled Krebs-Henseleit buffer with the following 
composition (mM): NaCl 118, KCl 4.7, KH2PO4 1.2, 
MgSO4.7H2O 1.17, CaCl2.2H2O 2.5, NaHCO3 25 and 
glucose 5.6. The proximal segment of the femoral artery 
was isolated and two rings (approximately 2 mm length) 
were taken and mounted in a 5 ml organ chamber. A 
wire myograph for isometric force recording (Danish 
Myo Technology, model 610M, Aarthus N, Denmark) 
coupled with an acquisition system with specific software 
(PowerLab 8/30, LabChart 7, ADInstruments, Sydney-NSW, 
Austrália). The bathing solution was maintained at 37°C and 
continuously gassed with 95%-O2 and 5%-CO2, with of pH 
7.4. The tissues were allowed to equilibrate for 60 minutes 
under a resting tension of 1 mN21.
Concentration-response curves to contractile agents
Following the equilibration period, the rings were 
precontracted with KCl 80 mM to verify the tissue viability 
and washed with Krebs. The rings were precontracted with 
phenylephrine (PE: 1 µM) and relaxed to acetylcholine 
(ACH: 1 µM) to confirm the endothelium integrity. Rings 
lacking contractile or relaxing responses were disposed of.
To evaluate the contractile responses mediated by 
serotoninergic and α-adrenergic receptors, cumulative 
concentration-response curves to 5-hydroxytryptamine 
(5-HT: 1 nM - 100 µM) and phenylephrine (PE: 1 nM - 
100 µM) were constructed in the proximal segment of the 
femoral artery rings22.
Concentration-response curves to isoproterenol (1 
nM - 10 mM) were obtained in precontracted tissues 
with PE (1 µM) or 5-HT (10 µM) to further analyze the 
interactions between b-adrenergic receptors activation 
and α-adrenergic or serotoninergic receptors. We also 
performed concentration-response curves to adenylyl 
cyclase activator, forskolin (1 nM - 100 µM) in femoral 
rings, to determine whether the drug interactions could be 
at receptor level or beyond.
All the concentration-response data were evaluated in 
order to fit into a logistics function in the formula:
E = Emax/((1 + (10c/10x)n) + F)
where E is the effect of above basal; Emax is the 
maximum response produced by the agonist; c is the 
logarithm of the EC50, the concentration of the agonist 
that produces half-maximal response; x is the logarithm 
of the concentration of the agonist; the exponential term, 
n is a curve-fitting parameter that defines the slope of the 
concentration response line, and F is the response observed 
in the absence of the agonist added. Nonlinear regression 
analysis was used to determine the parameters Emax and log 
EC50, by using GraphPad Prism (GraphPad Software Inc., San 
Diego, CA) with the constraint that F = 0. The responses 
for each agonist are shown as the mean ± SEM of potency 
(pEC50) and maximal response (Emax). The relaxations 
were plotted as percentages of the contractions induced by 
PE or 5-HT and the contractile responses were plotted as 
percentage of the concentration induced by KCl (80 mM).
Statistical analysis
The data are expressed as mean ± SEM of n experiments. 
Paired or unpaired Student’s t test was performed using 
specific software (InStat, GraphPad Software. La Jolla-CA, 
USA). Values of p < 0.05 were considered statistically 
significant.
Drugs
Acetylcholine chloride, phenylephrine hydrochloride, 
5-hydroxytryptamine, forskolin and isoproterenol were 
purchased from Sigma Chemical Co. (St Louis, MO, USA). 
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Results
Contractile responses 
Both 5-HT and PE produced concentration-dependent 
contractile responses in femoral artery rings (Figure 1A). 
The potency of 5-HT was significantly greater compared to 
the α1-agonist PE, approximately 20-fold, in the proximal 
segment of rat femoral artery. No differences were found 
in the maximal responses for both agonists. The data are 
summarized in Table 1. 
Relaxing responses
In another set of experiments, we evaluate the relaxing 
responses to β-adrenergic agonist isoproterenol where 
femoral artery rings were precontracted with PE (10 µM) 
or 5-HT (1 µM). In PE-precontracted rings, isoproterenol 
produced concentration-dependent relaxation responses. 
However, in 5-HT-precontracted rings, isoproterenol evoked 
a slight relaxing response in femoral artery rings compared 
to its paired PE-precontracted rings (Figure 1B). To further 
test the hypothesis that 5-HT-precontracted tissues were 
affecting at the level of β-adrenergic receptor or beyond 
(signaling pathway), concentration-response curves to 
the adenylyl cyclase activator forskolin were obtained 
in femoral artery rings precontracted with PE (10 µM) or 
5-HT (1 µM). In PE-precontracted rings, forskolin produced 
concentration-dependent relaxation responses. However, 
a parallel dextral displacement, approximately 9-fold, was 
observed in the concentration-response curves to forskolin 
in 5-HT precontracted tissues as compared to its paired PE-
precontracted femoral artery rings (Figure 1C). No differences 
were found in the maximal responses for adenylyl cyclase 
activator precontracting with both agents. All data are 
summarized in Table 1.
Discussion
In this study, we observed that the order rank potency 
in the proximal segment of femoral artery was 5-HT > PE 
for contractile responses that may reflect a greater density 
of serotoninergic receptors and/or high effectiveness of its 
signaling pathway mechanism in this preparation compared 
to the activation of α-adrenergic receptor/cAMP/PKA 
downstream pathway. Interestingly, a previous study found 
a similar rank potency for 5-HT in different artery rings 
including mesenteric, caudal and basilar23. Moreover, the 
potency for 5-HT found in our study for proximal segment 
in the femoral artery (6.86) was closely related to those 
obtained in the basilar artery (6.88) indicating that both 
preparations present great similarities in pharmacologic 
properties. Interestingly, clinical evidences have shown that 
PAD is more common in migraineurs than in controls24,25. 
Altogether, our data showed that femoral artery is an 
interestingly model to study serotoninergic receptor 
signaling pathway under normal and pathological conditions 
such as diabetes mellitus and atherosclerosis.
In this study, we have also found that precontracted 
tissues with 5-HT virtually abolished the relaxing responses 
to isoproterenol (10% of maximal responses) that was 
partially restored by forskolin, a direct-acting stimulant 
of adenylyl cyclase that bypass β-adrenergic receptors. 
Therefore, our findings showed an interaction between 
b-adrenergic- and serotoninergic- receptors signaling 
pathway in rat femoral artery. In this regard, a previous study 
demonstrated a cross-talk between β-adrenergic receptor 
and 5-HT1 on glutamate release in cerebrocortical nerve 
terminals26. Thus, our data reinforce that the proximal 
segment of the femoral artery is an interesting vascular tissue 
to study 5-HT receptors and its complex signaling pathway. 
However, we cannot ascertain from this study which 5-HT 
receptor subtype is mediating the contractile response 
Table 1 - Potency (pEC50) and maximal responses (Emax) values obtained from concentration-response curves to phenylephrine (PE), 
5-hydroxytryptamine (5-HT), isoproterenol (ISO) and forskolin in rat femoral artery rings precontracted with PE or 5-HT
pEC50 Emax
Contractile responses
PE 5.50±0.04 (10) 114±2
5-HT 6.86±0.01 (8)* 119±2
Relaxation responses
ISO 
(PE-precontracted) 5.33±0.08 (6) 95±2
ISO 
(5-HT-precontracted) ND (4) 10±1
†
Forskolin 




Potency is represented as -log of molar concentration to produce 50% of the maximal response. Data represent the mean ± S.E.M. of 4-10 experiments. ND: 
not determined. Number of experiments is shown in parentheses. *p < 0.05 compared to PE contractile responses. †p < 0.05 compared to ISO relaxation in 
PE-precontracted tissues.‡p < 0.05 compared to forskolin relaxation in PE-precontracted tissues.
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Figure 1 - Concentration-response curves to phenylephrine (•PE, n = 10) and 5-hydroxytryptamine (∇5-HT, n = 08) in rat femoral artery (panel A). Relaxations induced 
by isoproterenol precontracted with PE (10 µM, n = 06, •) or 5-HT (1 µM; n = 4, ∇) in rat femoral artery (panel B). Relaxations induced by forskolin precontracted with 
PE (10 µM, n = 04, •) or 5-HT (1 µM; n = 5, ∇) in the rat femoral artery (panel C). Data are means ± SEM.
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and/or which transduction effectors are contributing to 
the suppression of the β-adrenergic receptor-mediating 
relaxation in rat femoral artery. Evidence has shown that the 
5-HT1 receptors family is mostly linked to Gi/o, which are 
pertussis toxin sensitive and negatively coupled with adenylyl 
cyclase9. On the other hand, β-adrenergic receptor activation 
is coupled to Gs protein which in turn leads to the activation 
of cAMP/PKA signaling pathway in the cardiovascular 
system19. Thus, the antagonistic cross-talk between 5-HT 
receptors and β-adrenergic receptor could be occurring at 
G-protein-coupled receptor as well as at the level of PKA 
substrates since forskolin partially restored the suppression 
of the β-adrenergic receptor-mediating relaxation in 
5-HT-precontracted rat femoral artery ring. The functional 
significance of these data may be related to the incidence 
of vascular disease and 5-HT agonists/5-HT uptake blockers 
administration in some disorders such migraine and obesity.
Conclusion
In conclusion, our data showed clearly that an 
interaction between b adrenergic- and serotonergic- 
receptors signaling pathway occurs in rat femoral artery 
rings. Moreover, this study provides an interesting 
perspective to study serotoninergic receptor signaling 
pathway under normal and pathological conditions in 
an attempt to improve the clinical outcomes in patients 
with PAD.
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